Application
Western blot analysis of PLEKHA1 (arrow) using rabbit polyclonal PLEKHA1 Antibody (Center) . 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the PLEKHA1 gene.| Product Name | PLEKHA1 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | PLEKHA1; TAPP1; Pleckstrin homology domain-containing family A member 1; Tandem PH domain-containing protein 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | TAPP1 |
|---|---|
| Alternative Names | PLEKHA1 TAPP1 Pleckstrin homology domain-containing family A member 1 Tandem PH domain-containing protein 1 |
| Molecular Weight(MW) | 45553 Da |
| Function | Binds specifically to phosphatidylinositol 3,4- diphosphate (PtdIns3,4P2), but not to other phosphoinositides. May recruit other proteins to the plasma membrane |
| Tissue Specificity | Highly expressed in skeletal muscle, thymus, pancreas, placenta and lung. Detected at low levels in brain, heart, peripheral blood leukocytes, testis, ovary, spinal cord, thyroid, kidney, liver, small intestine and colon |
| Cellular Localization | Cytoplasm. Cell membrane; Peripheral membrane protein. Nucleus. Note=Locates to the plasma membrane after treatments that stimulate the production of PtdIns3,4P2 |
| Entrez Gene | 59338 |
|---|---|
| Nucleotide Accession | NP_001001974.1 |
Application
Western blot analysis of PLEKHA1 (arrow) using rabbit polyclonal PLEKHA1 Antibody (Center) . 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the PLEKHA1 gene.| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
